Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Gravity surveys using a mobile atom interferometer.

Wu X, Pagel Z, Malek BS, Nguyen TH, Zi F, Scheirer DS, Müller H.

Sci Adv. 2019 Sep 6;5(9):eaax0800. doi: 10.1126/sciadv.aax0800. eCollection 2019 Sep.

2.

The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura.

Guo NH, Fu X, Zi FM, Song Y, Wang S, Cheng J.

Int Immunopharmacol. 2019 Aug;73:181-192. doi: 10.1016/j.intimp.2019.04.061. Epub 2019 May 16.

PMID:
31102993
3.

Sensitive assay of Escherichia coli in food samples by microchip capillary electrophoresis based on specific aptamer binding strategy.

Zhang Y, Zhu L, He P, Zi F, Hu X, Wang Q.

Talanta. 2019 May 15;197:284-290. doi: 10.1016/j.talanta.2019.01.040. Epub 2019 Jan 11.

PMID:
30771937
4.

I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma.

Guo NH, Zheng JF, Zi FM, Cheng J.

Biosci Rep. 2019 May 14;39(5). pii: BSR20181245. doi: 10.1042/BSR20181245. Print 2019 May 31.

5.

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells.

Zhao Y, Zhang E, Lv N, Ma L, Yao S, Yan M, Zi F, Deng G, Liu X, He J, Wu W, Cai Z, Yu R.

Cell Physiol Biochem. 2018;48(2):785-800. doi: 10.1159/000491908. Epub 2018 Jul 20.

6.

Role of interleukin-32 in cancer biology.

Yan H, He D, Huang X, Zhang E, Chen Q, Xu R, Liu X, Zi F, Cai Z.

Oncol Lett. 2018 Jul;16(1):41-47. doi: 10.3892/ol.2018.8649. Epub 2018 May 7. Review.

7.

Metformin and cancer: An existing drug for cancer prevention and therapy.

Zi F, Zi H, Li Y, He J, Shi Q, Cai Z.

Oncol Lett. 2018 Jan;15(1):683-690. doi: 10.3892/ol.2017.7412. Epub 2017 Nov 14.

8.

Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.

Lin X, Yang L, Wang G, Zi F, Yan H, Guo X, Chen J, Chen Q, Huang X, Li Y, Zhang E, Wu W, Yang Y, He D, He J, Cai Z.

Oncotarget. 2017 Oct 7;8(54):92841-92854. doi: 10.18632/oncotarget.21611. eCollection 2017 Nov 3.

9.

Multifocus autofocusing Airy beam.

Li T, Zi F, Huang K, Lu X.

J Opt Soc Am A Opt Image Sci Vis. 2017 Sep 1;34(9):1530-1534. doi: 10.1364/JOSAA.34.001530.

PMID:
29036156
10.

I‑BET151 inhibits osteoclastogenesis via the RANKL signaling pathway in RAW264.7 macrophages.

Cheng J, Zheng J, Guo N, Zi F.

Mol Med Rep. 2017 Dec;16(6):8406-8412. doi: 10.3892/mmr.2017.7631. Epub 2017 Sep 26.

PMID:
28983590
11.

Laser frequency stabilization by combining modulation transfer and frequency modulation spectroscopy.

Zi F, Wu X, Zhong W, Parker RH, Yu C, Budker S, Lu X, Müller H.

Appl Opt. 2017 Apr 1;56(10):2649-2652. doi: 10.1364/AO.56.002649.

PMID:
28375231
12.

Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models.

He D, Guo X, Zhang E, Zi F, Chen J, Chen Q, Lin X, Yang L, Li Y, Wu W, Yang Y, He J, Cai Z.

Oncotarget. 2016 Jul 19;7(29):45489-45499. doi: 10.18632/oncotarget.9993.

13.

Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).

Zi F, He J, He D, Li Y, Yang L, Cai Z.

Mol Med Rep. 2015 May;11(5):3203-11. doi: 10.3892/mmr.2015.3197. Epub 2015 Jan 14. Review.

14.

Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.

Zi FM, He JS, Li Y, Wu C, Yang L, Yang Y, Wang LJ, He DH, Zhao Y, Wu WJ, Zheng GF, Han XY, Huang H, Yi Q, Cai Z.

Cancer Lett. 2015 Jan 28;356(2 Pt B):443-53. doi: 10.1016/j.canlet.2014.09.050. Epub 2014 Oct 8.

PMID:
25305450
15.

Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.

Zi FM, He JS, Li Y, Wu C, Wu WJ, Yang Y, Wang LJ, He DH, Yang L, Zhao Y, Zheng GF, Han XY, Huang H, Yi Q, Cai Z.

Cancer Biol Ther. 2014 Oct;15(10):1413-22. doi: 10.4161/cbt.29924. Epub 2014 Jul 21.

16.

TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Zhao Y, Liu Q, Yang L, He D, Wang L, Tian J, Li Y, Zi F, Bao H, Yang Y, Zheng Y, Shi J, Xue X, Cai Z.

Cell Mol Immunol. 2013 Mar;10(2):165-75. doi: 10.1038/cmi.2012.58. Epub 2012 Dec 24.

17.

Note of clarification of data in the meta-analysis of methylenetetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.

Chan Y, Zi F, Wu X, Ma L, Meng Y, Chen J, Wang S, Luo S, Luo Y, Tang W.

Mol Hum Reprod. 2012 Oct;18(10):514-5. Epub 2012 Jun 15. No abstract available.

PMID:
22707671
18.

[Study on the ingredients of reserpine by TLC-FT-SERS].

Wang Y, Zi F, Wang Y, Zhao Y, Zhang X, Weng S.

Guang Pu Xue Yu Guang Pu Fen Xi. 1999 Dec;19(6):824-6. Chinese.

PMID:
15822308
19.

[TLC-FT-SERS study on ingredients of Isrhynchophylline].

Wang Y, Wang SY, Zhao YX, Ren GF, Zi FL.

Guang Pu Xue Yu Guang Pu Fen Xi. 2002 Feb;22(1):43-5. Chinese.

PMID:
12940023

Supplemental Content

Support Center